CLINICAL_TRIALS
withdrawal
· 2021-05-05
Clinical Trial Update: Strategies to Reduce Organic Muscle Atrophy in the Intensive Care Unit [Phase 2, Phase 3]
Summary
Clinical trial update indicating withdrawal of a Phase 2/Phase 3 study investigating strategies to reduce muscle atrophy in ICU patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Muscle Atrophy | Phase 2, Phase 3 | Status: WITHDRAWN